glp-1 cv outcome trials The Big Trial of a drug (Wegovy) to Reduce Major Cardiovascular Events Targeting the weight within: obesity

There are several types of GLP-1 medications used for diabetes treatment

For GLP-1s for overweight adults, the FDA label says they should have at least one additional, unspecified health risk

PlexusDx supports this conversation by combining clinical evidence with genetic insights into peptide pathway sensitivity, helping you and your provider anticipate individual response patterns

Total expected weight regain during a 6-week holiday with proper nutrition management: 3-8 pounds

E., Murphy, N., Patel, A

Potential Benefits and Risks of Microdosing GLP-1 Microdosing GLP-1 is proposed to reduce dose-dependent gastrointestinal side effects such as nausea and vomiting, but lacks randomised controlled trial evidence for efficacy or safety